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ABSTRACT
Objectives: Fetal lower urinary tract obstruction (LUTO), most often associated with presence of posterior urethral valves, 
poses high risk of perinatal mortality or postnatal renal failure. Looking for a method of causative treatment we have devel-
oped a technique of fetal urethroplasty with a coronary angioplasty balloon catheter inserted under an ultrasonographic 
guidance via an 18-gauge needle introduced transabdominally to fetal bladder.
Material and methods: We have used this procedure in three women with singleton pregnancies (two primiparas and one 
multipara, 32–35 years of age), diagnosed with fetal megacystis at 12–16 weeks of gestation. Urethral catheterization was 
carried out at 16–18 weeks and an unobstructed urine flow was achieved in all three cases immediately after the procedure, 
followed by a resolution of megacystis and normalization of amniotic fluid volume.
Results: In all three cases, the post-procedure period was uneventful. In the first two fetuses, amniotic fluid volume re-
mained normal until 30 weeks of gestation when a gradual development of oligohydramnios and some signs of renal cystic 
dysplasia were observed. Nevertheless, both pregnancies were continued till term (37 and 39 weeks, respectively) and two 
boys without signs of pulmonary hypoplasia were delivered. The third patient is currently 25 weeks pregnant; volume of 
amniotic fluid in her fetus is normal and no signs of urinary flow obstruction or renal dysplasia have been recorded thus far.
Conclusions: Although some technical aspects of the procedure still need to be established, it seems worth consideration 
as a form of potentially least traumatic intrauterine intervention in fetuses with lower urinary tract obstruction.
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INTRODUCTION
Fetal lower urinary tract obstruction (LUTO) is a group 
of congenital conditions diagnosed with a frequency of ap-
proximately 2.2 per 10 000 births. Two most common causes 
of LUTO are posterior urethral valves (PUVs) and urethral 
atresia. Other isolated malformations include anterior ure-
thral valves and urethral stenosis/hypoplasia. LUTO may be 
also a component of various congenital syndromes, such as 
megacystis-microcolon syndrome, megacystis-megaureter 
syndrome, prune-belly syndrome and chromosome 18, 
13 and 21 aneuploidy. LUTO causes an increase in urinary 
pressure, which may impede the development of collecting 
ducts, tubules and glomeruli, and eventually results in renal 
dysplasia. Lack of urine output leads to oligohydramnios, 
pulmonary hypoplasia, Potter sequence and preterm birth 
[1–4]. LUTO is associated with high mortality or high risk of 
renal failure in the childhood [5]. Neonates with complete 
PUVs and anhydramnios usually die shortly after birth due 
to pulmonary hypoplasia. Urine output and amniotic fluid 
volume in fetuses with uncomplete PUVs may be initially 
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normal or only slightly reduced; however, urinary pressure 
is still elevated, which may contribute to gradual kidney 
damage and renal insufficiency after birth.
LUTO is usually diagnosed during routine ultrasound 
in the second trimester, except from the most severe forms 
which are detected already in the first trimester [6]. Typi-
cal symptoms of LUTO include megacystis with a keyhole 
sign, bilateral hydronephrosis with or without cystic renal 
changes, and oligohydramnios or anhydramnios. Available 
management options include expectant management, ter-
mination of pregnancy or intrauterine intervention. Unfortu-
nately, we lack an accurate method to identify fetuses that 
may really benefit from in utero treatment, and in many 
cases renal damage at the time of intervention is too ad-
vanced to prevent further deterioration of kidney function [7]. 
A few prenatal procedures can be offered to fetuses with 
LUTO [8], with vesicoamniotic shunting (VAS) being the 
standard treatment. Also successful attempts to perform 
open fetal vesicostomy or fetal cystoscopic laser ablation of 
the valves have been reported. Ruano et al. [9] and Hofmann 
et al. [10] presented their single experience with fetoscopic 
retrograde catheterization of fetal urethra with a guidewire 
and transurethral stent placement. In this report, we present 
three cases of LUTO treated by dilatation of fetal urethra 
with a coronary balloon catheter under an ultrasonographic 
guidance. To the best of our knowledge, this kind of intrau-
terine intervention has not been reported thus far.
MATERIAL AND METHODS
Patient #1, a 32-year-old primipara was referred to hos-
pital at 17 weeks of gestation with the diagnosis of mega-
cystis and oligohydramnios. Despite a slight increase in 
renal echogenicity, no distention was observed in either 
the renal pelvis or calyces. The keyhole sign, typical ultra-
sonographic manifestation of PUVs was documented, with 
distended fetal bladder reaching up to 64 mm in height. 
Patient #2, a 34-year-old primipara was admitted at 16 weeks 
of gestation. Also in this case, an evident fetal megacystis 
(bladder height 41 mm) was detected, along with the key-
hole sign and slight bilateral ureteral dilation. Similar to the 
first case, no ultrasonographic abnormalities of the kidneys 
were found except from a slight increase in echogenicity. 
Amniotic fluid volumes in both patients were at lower nor-
mal limit. In Patient #1, ultrasonographic evidence of fetal 
megacystis was found at 11–14 weeks scan. Patient #2 did 
not undergo an ultrasonographic exam prior to 16 weeks 
of gestation. Patient #3 was a 35-year-old woman in her 
fourth pregnancy, with a history of two miscarriages and one 
termination due to trisomy 21. Ultrasonographic findings 
at 11–14 weeks scan were normal, and the first evidence 
of megacystis emerged at 16.4 weeks of gestation. At the 
time of diagnosis, urinary bladder had 34 mm in length. The 
kidneys were slightly hyperechoic with a mild hydronephro-
sis (normal AP diameter of renal pelvis but with an evident 
distention of the calyces). Amniotic fluid volume was at 
lower normal limit. Aside from club foot deformity in fetus 
from Patient #1, no other ultrasonographic and echocar-
diographic anomalies were found, and amniocentesis and 
genetic analysis (aCGH) demonstrated presence of normal 
46,XY fetal karyotype in all cases.
Upon being informed about prognosis and available 
management options, all pregnant women consented for 
balloon catheter dilatation procedure.
The procedure was carried out under maternal local 
anesthesia and fetal anesthesia with fentanyl and atracurium 
(30 µg/kg estimated fetal weight [EFW] and 0.2 mg/kg EFW, 
respectively, injected to fetal gluteal muscle). Fetal urethra 
was dilated with a Maverick 2 balloon catheter (the dia- 
meter of the leader of the catheter is 0,014’’ and diameter 
of the balloon is 2 mm, length 9 mm, the crossing profile 
of un uninflated balloon is less then 1 mm) inserted under 
an ultrasonographic guidance. In Patient #1, the interven-
tion took place at 17 + 3 weeks of gestation. An 18-gauge 
(G) needle, introduced to fetal bladder transabdominally, 
was used to insert the coronary catheter to the urethra. After 
positioning the catheter, the balloon was inserted. Although 
the fetus was in a cephalic position, the exact location of the 
catheter in the urethra could not be visualized clearly due 
to maternal obesity and anterior location of the placenta. 
Owing these technical difficulties and small size of fetal 
urethra, the balloon was inserted and retracted a few times 
instead of being inflated (diameter of the balloon is larger 
than the catheter’s diameter). In Patient #2, the procedure 
was carried out at 16 + 5 weeks of gestation, using the 
same protocol of anesthesia as described above. Due to 
an unfavorable position of the fetus, with pelvis close to the 
internal os of the cervix, a transvaginal transducer was used 
after transabdominal insertion of the needle to fetal blad-
der. Then, similarly the guide wire was inserted to fetal ure-
thra, followed by a coronary balloon catheter. In Patient #3, 
the procedure was carried out at 18.1 weeks of gestation. 
During nearly two weeks between the diagnosis of LUTO 
and the intervention, the status of fetal urinary tract has de-
teriorated considerably. Prior to the procedure, the bladder 
was 61 mm in length, AP diameter of renal pelvis equaled 
to 5 mm, and evidently distended renal calyces could be 
observed along with bilateral megaureters. Similar to pre-
viously described cases, an 18-G needle was inserted via 
uterine wall into the fetal bladder under a transabdominal 
ultrasonographic guidance (Fig. 1), and then the procedure 
was monitored using a transvaginal ultrasound. A balloon 
catheter was inserted to fetal urethra, reaching down to the 
amniotic cavity (Figs. 2, 3). The balloon was slightly inflated 
manually under an ultrasonographic guidance in the three 
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different segments of the urethra (Fig. 4), corresponding to 
entire length of the urethra, and then removed.
RESULTS
An unobstructed urine flow was observed in all three cas-
es immediately after the procedure, followed by a resolution 
of megacystis. Control ultrasonographic exam performed 
one day later confirmed decompression of thick-walled 
urinary bladder and normal volume of amniotic fluid. The 
post-procedure period was uneventful in all three cases.
In fetus from Patient #1, amniotic fluid volume remained 
normal until 30 weeks of gestation, when the first ultrasono-
graphic evidence of oligohydramnios emerged on a control 
ultrasound, along with the signs of progressive renal cystic 
dysplasia. Male newborn was delivered vaginally at 39 weeks 
of gestation with a 7-point Apgar score, which reflected 
presence of transient respiratory problems. During the first 
day of life, until normalization of respiratory function, the 
neonate required mechanical ventilation in bi-pap. Ultra-
sonographic exam revealed bilateral renal dysplasia, without 
parenchymatous-medullar differentiation, as well as the 
presence of tiny cysts in the left kidney. Urine output was 
normal (1.6–2.6 mL/kg/hour), and no signs of infection were 
observed. Serum creatinine was 0.7 mg/dL on the first day 
of life, but then raised to 3.7 mg/dL. An urethrocystoscopy 
performed at the Urology Department confirmed presence 
of residual PUVs without urine flow obstruction. However, 
forced diuresis, antibiotic therapy, natrium bicarbonate and 
vitamin D supplementation were introduced due to the evi-
dence of renal dysplasia. Further, the club deformity in the 
right foot has been corrected. The neonate was discharged 
from the Pediatric Urology Department at one month of 
age, in a good general condition, with serum creatinine 
2.3 mg/dL. Vitamin D and calcium supplementation were 
prescribed and further follow-up at a nephrology and uro- 
logy unit was recommended. Serum creatinine increased up 
to 3.4 mg/dL at 8 months of age, which constituted an in-
dication to dialysis therapy. Currently, at 15 months of age, 
the boy urinates independently but is also is still subjected 
to peritoneal dialyses (2–3 times weekly) and his serum cre-
atinine approximates 5.4 mg/dL. Meanwhile, he underwent 
a cryptorchidism surgery, and awaits a kidney transplant. 
Otherwise he develops normally. Owing retained function 
of the bladder, he is scheduled for kidney transplantation 
to his own bladder, which is the most comfortable option to 
provide him with normal quality of life in the future.
Figure 2. Balloon catheter in proximal fetal urethra (Patient #3)Figure 1. 18-G needle in fetal megacystis (Patient #3)
Figure 3. Balloon catheter in fetal penile urethra (Patient #3) Figure 4. Inflated balloon in fetal urethra (Patient #3)
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Further course of pregnancy in Patient #2 was unevent-
ful as well. Amniotic fluid volume remained normal until 
30 weeks of gestation when a gradual development of 
oligohydramnios and signs of renal cystic dysplasia were 
observed. Male neonate was delivered via the cesarean at 
37 weeks of gestation, with 8–9–10-point Apgar score. The 
decision to perform the cesarean was driven by the evi-
dence of fetal asphyxia during the course of vaginal birth. 
Ultrasonography confirmed presence of small, hypoecho-
genic kidneys with a parenchymatous cyst and bilateral 
ureter distention. Laboratory tests revealed elevated levels 
of inflammatory markers and pyuria; serum creatinine 
amounted to 2.8 mg/dL. Third-generation cephalosporine 
was implemented due to presence of Escherichia coli and 
Klebsiella pneumoniae infection. The neonate underwent 
a cystoscopy with transurethral incision (TUI) of residual 
PUVs and cervix of the bladder at Urology Department. 
The boy was discharged home at 3 weeks of age, in a good 
general condition, with serum creatinine level of 1.4 mg/dL, 
and recommendation of further follow-up at a nephrology 
and urology unit. Unfortunately, he required creation of 
an uretero-cutaneous fistula due to presence of persistent 
megaureter on the left side. Currently, at 7 months of age, 
the boy urinates freely and presents with normal serum cre-
atinine (0.9 mg/dL) and does not require a renal replacement 
therapy. Noticeably, fetuses from Patients #1 and #2 were 
delivered at term, and the cesarean section in Patient #2 was 
necessary solely due to obstetrical indications. Patient #3 is 
currently 27 weeks pregnant; volume of amniotic fluid in her 
fetus is normal and no signs of urinary flow obstruction has 
been recorded thus far.
DISCUSSION
Treatment of fetal LUTO remains an unresolved and wide-
ly discussed problem of prenatal therapy. Prenatal interven-
tions in fetuses with LUTO, aimed at prevention or at least 
reduction of postnatal morbidity and mortality, date back to 
1982, when Harrison et al. [11] reported a case of severe fetal 
bilateral hydronephrosis treated by ureterostomy. The out-
comes of the intrauterine treatment of LUTO has improved 
since then, and some techniques, such as vesicoamniotic 
shunting (VAS), fetoscopic laser ablation of the PUVs and 
even a cystoscopic transurethral stent placement have been 
implemented. Long-term postnatal outcomes in children 
after intrauterine VAS were a subject of many previous stud-
ies. Freedman et al. [12] and Holmes et al. [13] performed this 
procedure in 34 and 14 fetuses with LUTO, respectively, with 
60% and 57% survival rates, and normal kidney function in 
43% and 37% of the cases, respectively. These findings are 
consistent with the results of other studies in which VAS 
resulted in normalization of fluid volume and normal renal 
function in only 50% [14] and 45% of neonates [15]. PLUTO 
trial was originally designed to include 150 women with sin-
gleton pregnancies with ultrasonographic evidence of LUTO, 
randomized to either VAS or conservative management. 
However, only 31 patients have been eventually recruited; 
after a 1-year follow-up, only 2/7 neonates subjected to VAS 
showed no evidence of renal dysfunction [16]. To summarize, 
most findings imply that VAS neither eliminates the cause 
of LUTO nor effectively prevents the resultant renal dam-
age. It has many disadvantages, like incorrect placement, 
displacement, urinary ascites formation but probably the 
most important is that it affects bladder function because 
the presence of bladder shunt precludes a normal urination 
cycle. The bladder is spastic after birth and causes an increase 
in urinary pressure which often contributes to vesicoureteral 
reflux and secondary hydronephrosis.
An attempt to resolve the issue of fetal PUVs is their 
fetoscopic laser fulguration. This procedure was first per-
formed by Sananes et al. [17] in 23 fetuses with LUTO; 60.9% 
of them survived (14/23) and 85.7% (12/14) of them had 
normal renal function after birth. The only documented 
procedure of cystoscopic transurethral stent placement 
was performed by Ruano et al. [9] at 22 weeks of gestation; 
currently, their patient is at 5 years of age and still presents 
with normal renal function. The main technical drawback of 
fetal cystoscopy are difficulties in reaching posterior urethra, 
since generally sharp vesicourethral angle becomes even 
sharper with gestational age. Therefore, even if posterior 
urethra can be reached, urethral valves may not be ad-
equately visualized. This represents a serious limitation of 
fetal cystoscopy and potential cause of significant morbidity, 
such as fistula formation or inadvertent thermal damage 
to surrounding tissues. Up to 10% of newborns subjected 
to cystoscopy in utero presented with urological fistulas at 
birth [17]. Furthermore, long-term complications of intrau-
terine cystoscopy may potentially interfere with sexual life 
and fertility in the adulthood. All this problems with prenatal 
LUTO management justifies further research on causative 
and less invasive intrauterine treatment of LUTO.
To overcome the technical limitations of fetoscopic pro-
cedure and to avoid the complications inherent either to 
fetoscopy or to VAS, we have developed our own technique 
of fetal urethroplasty with a coronary angioplasty balloon 
catheter. The first advantage of this technique is its less 
invasive character. Further, the whole procedure is carried 
out under an ultrasonographic guidance, which may provide 
an excellent visualization of the coronary catheter as well as 
the fetal bladder and the urethra. Secondly, the flexible and 
trackable catheter can be easily diverted into all directions 
and inserted into even very narrow and tight spaces. This 
is exactly the same type of catheter which we use during 
fetal balloon cardiac valvuloplasties at our center [18–20]. 
It can be introduced into the valve with down to 1 mm in 
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diameter, because the diameter of the leader of the catheter 
is only 0.014’’ (0.35 mm).
To this date, a total of three procedures of balloon cath-
eterization have been carried out at our center in fetuses 
with suspected isolated PUVs. The treatment produced sat-
isfactory outcomes regarding intrauterine relieving of the 
obstruction; as a result of restoring urinary patency, none 
of the fetuses presented with megacystis or hydronephrosis 
till the end of the pregnancy. Unfortunately, despite suc-
cessful catheterization of the urethra, progressive oligohy-
dramnios and cystic renal dysplasia have been observed in 
two fetuses in late pregnancy, perhaps as a consequence 
of earlier irreversible damage to kidney tissue. Patient #3 is 
still pregnant but her fetus shows no signs of lower urinary 
tract obstruction and the kidneys look normally. To the 
best of our knowledge, this is the ﬁrst report documenting 
ultrasound-guided insertion of a balloon catheter to fetal 
urethra as an intrauterine approach to fetal megacystis. Al-
though the efﬁcacy and technical aspects of the procedure 
still need to be established, it seems to be an option of fetal 
PUV treatment worth consideration. Intrauterine catheteri-
zation restores patency of lower urinary tract without a dam-
age to fetal urethra and surrounding tissues. Furthermore, 
in contrast to VAS, this procedure does not interfere with 
normal micturition and urinary bladder function during 
the pregnancy. Since fetal urethra is dilated only mechani-
cally and the catheter is removed immediately after the 
procedure, there is no risk of thermal destruction or long 
term irritation of surrounding tissues.
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